A Phase I Study of ATR Inhibitor BAY1895344 (elimusertib) Plus Topotecan (ETCTN 10402): Results of Dose Escalation.
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined